Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer
Bu, X.-m.; Zhao, C.-h.; Dai, X.-w.
Chinese Medical Journal 121(10): 952-955
2008
ISSN/ISBN: 0366-6999 PMID: 18706212 Document Number: 615508
Document emailed within 1 workday
Related Documents
Ozawa, H.; Matsunaga, T.; Kamiya, K.; Tokumaru, Y.; Fujii, M.; Tomita, T.; Ogawa, K. 2007: Decreased expression of connexin-30 and aberrant expression of connexin-26 in human head and neck cancer Anticancer Research 27(4b): 2189-2195Jamshidipour, R.; Pinho, E.B.; Howell, S.B. 1994: In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts Anticancer Research 14(6b): 2611-2616
Liu, Q.; Wang, C.-F.; Zhou, Z.; Hu, H.; Zhao, D.-B.; Ni, X.-G.; Bai, X.-F.; Gao, J.-D.; Tian, Y.-T.; Zhao, P. 2007: Expression of annexin i in human pancreatic cancer and the influence of its down-regulation on biology of this cancer Zhonghua Zhong Liu Za Zhi 29(10): 738-741
Alberti, C. 2016: Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications European Review for Medical and Pharmacological Sciences 20(6): 1001-1002
Unek, T.; Unek, I.T.; Agalar, A.A.; Sagol, O.; Ellidokuz, H.; Ertener, O.; Oztop, I.; Karademir, S.; Yilmaz, U.; Astarcioglu, I. 2013: CD40 expression in pancreatic cancer Hepato-Gastroenterology 60(128): 2085-2093
Kim, Y.S.; Itzkowitz, S.H.; Yuan, M.; Chung, Y.; Satake, K.; Umeyama, K.; Hakomori, S. 1988: Lex and Ley antigen expression in human pancreatic cancer Cancer Research 48(2): 475-482
Hong, S.P.; Shin, S.K.; Bang, S.; Park, S.W.; Chung, J.B.; Lee, W.J.; Song, S.Y. 2009: Prognostic value of thymidine phosphorylase expression for pancreatic cancer Hepato-Gastroenterology 56(93): 1178-1182
Mou, H.; Yu, L.; Zheng, X.; Liao, Q.; Hou, X.; Wu, Y. 2017: P16 gene expression in pancreatic cancer tissue and its importance in diagnosis Journal of Biological Regulators and Homeostatic Agents 31(4): 1043-1047
Wen, Q.; Zhao, Y.-p.; Chen, G.; Zhang, F.-q.; Zhang, T.-p. 2006: Expression of S100A2 in secondarily radioresistant pancreatic cancer cells and significance thereof Zhonghua Yi Xue Za Zhi 86(40): 2817-2820
Bobarykina, A.Y.; Minchenko, D.O.; Opentanova, I.L.; Moenner, M.; Caro, J.; Esumi, H.; Minchenko, O.H. 2006: Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers Acta Biochimica Polonica 53(4): 789-799
Dang, C.-X.; Han, Y.; Qin, Z.-Y.; Wang, Y.-J. 2002: Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer Hepatobiliary and Pancreatic Diseases International: Hbpd Int 1(2): 302-305
Buscail, L.; Saint-Laurent, N.; Chastre, E.; Vaillant, J.C.; Gespach, C.; Capella, G.; Kalthoff, H.; Lluis, F.; Vaysse, N.; Susini, C. 1996: Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer Cancer Research 56(8): 1823-1827
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Zhang, S.; Cai, X.; Huang, F.; Zhong, W.; Yu, Z. 2008: Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3 Experimental Oncology 30(4): 265-268
Miyashita, T.; Tajima, H.; Shoji, M.; Nakanuma, S.; Sakai, S.; Makino, I.; Hayashi, H.; Nakagawara, H.; Takamura, H.; Kitagawa, H.; Ohta, T. 2013: Gemcitabine augments major histocompatibility complex class I-related chain a expression in pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1600-1602
Li, K.; Li, M.-j.; He, T.; Zheng, Z.; Zheng, X.-l.; Qu, B.-h.; Wang, Y.; Duan, X.; Zheng, Y.-j. 2009: Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis Zhonghua Yi Xue Za Zhi 89(34): 2386-2390
Lygidakis, N.J.; Papadopoulou, P. 1995: Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Hepato-Gastroenterology 42(5): 587-596
Yue, H.; Song, F.-L.; Zhang, N.; Feng, X.-L.; An, T.-Y.; Yu, J.-P. 2003: Expression of p27(kip1), Rb protein and proliferating cell nuclear antigen and its relationship with clinicopathology in human pancreatic cancer Hepatobiliary and Pancreatic Diseases International: Hbpd Int 2(1): 142-146
Eglinton, T.; Watson, A. 2004: Medical image. Magnetic resonance cholangiopancreatography (MRCP) demonstrating cholecystolithiasis and aberrant pancreatic duct anatomy New Zealand Medical Journal 117(1197): U962
Eglinton, T.; Watson, A. 2004: Medical image. Magnetic resonance cholangiopancreatography (MRCP) demonstrating cholecystolithiasis and aberrant pancreatic duct anatomy New Zealand Medical Journal 117(1197): U962